Imricor Medical Systems, - FDA to Conduct Pre-Approval Inspection of Imricor's Manufacturing Sites

Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module

Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Tissue Repair - Resumes Direct Distribution of Tr Pro+ in Australia and New Zealand

Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements

PAR Technology Launches Platform to Connect Restaurant Guest Data

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Australia's Monash IVF at over Four-Month High on Upbeat FY27 Outlook

CSL's U.S. Agreements Remove Two Stock Overhangs

Racura Oncology Says First South Korean Site Activated for Phase 1 Drug Candidate Trial in Advanced Solid Tumors

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing